GLPwatch

A Revolution in the Treatment of Obesity.

Am J Med · 2024

Last updated 2026-05-28

Up to 40% of Americans are obese and 20% are overweight, and until recently, weight loss options were limited. A new class of drugs called incretins has been developed, leading to weight loss of about 20 to 25% of body weight in obese patients.

AI summary of the abstract below.

JournalAm J Med, 2024
Citations4
Relative citation ratio0.90
NIH percentile47
Molecules
Conditions studied Obesity

Abstract

Forty percent of Americans are obese and 20% are overweight. Until recently, notwithstanding great efforts to combat this chronic, worsening epidemic, the only therapy that "worked" was surgery. However, recently, a new class of safe drugs (incretins) have been developed that cause obese patients to lose ∼20 to 25% of their body weight. Herein we recount this revolution and its implications.

Verbatim abstract via PubMed 38788825 ↗